DOCSLIB.ORG

Allgemeine Innere Medizin Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Allgemeine Innere Medizin Abstracts Primary Care and Hospital Allgemeine Innere Medizin Supplementum 5 1. Frühjahrsversammlung der SGAIM ad Primary and Hospital Care 1ère Assemblée de printemps SSMIG 2016;16: Heft 9 18. Mai 2016 Basel (Switzerland), 25.–27. Mai 2016 Abstracts Offizielles Organ Schweizerische Gesellschaft für Allgemeine INNere MediziN Haus- und Kinderärzte Schweiz www.primary-hospital-care.ch INHALT / SOMMAIRE 1 SGAIM 2016 – Freie Mitteilungen / SSMIG 2016 – Communications libres 3 FM230–FM233 Freie Mitteilungen SGAIM / Communications libres SSMIG: Allgemeine Innere Medizin / Médecine interne générale 1 5 FM235–FM239 Freie Mitteilungen SGAIM / Communications libres SSMIG: Kardiologie / Cardiologie 6 FM240–FM244 Freie Mitteilungen SGAIM / Communications libres SSMIG: Allgemeine Innere Medizin / Médecine interne générale 2 8 FM245–FM250 Freie Mitteilungen SGAIM / Communications libres SSMIG: Infektiologie / Infectiologie 11 FM251–FM256 Freie Mitteilungen SGAIM / Communications libres SSMIG: Allgemeine Innere Medizin / Médecine interne générale 3 14 FM257–FM262 Freie Mitteilungen SGAIM / Communications libres SSMIG: Pneumologie, Gastroenterologie, Notfall / Pneumologie, Gastroentérologie, Urgences 16 FM263–FM266 Freie Mitteilungen SGAIM / Communications libres SSMIG: Endokrinologie, Onkologie / Endocrinologie, Oncologie 18 FM267–FM274 Freie Mitteilungen SGAIM / Communications libres SSMIG: Ambulante Allgemeine Innere Medizin/Hausarztmedizin / Médecine interne générale ambulatoire/Médecine de famille 21 FM275–FM280 Freie Mitteilungen SGAIM / Communications libres SSMIG: Beste Freie Mitteilungen / Meilleures communications libres 24 FM281–FM290 Gastgesellschaft SFGG / Société conviée SPSG: Freie Mitteilungen / Communications libres 27 FM291–FM294 Gastgesellschaft SGH / Société conviée: SSH: Presidential Symposium 28 FM296–FM300 Gastgesellschaft SGH / Société conviée SSH: Experimental Hematology 30 FM301–FM305 Gastgesellschaft SGH / Société conviée: SSH: Clinical Hematology 32 FM306–FM310 Gastgesellschaft SGH / Société conviée SSH: Hemostasis, Vascular Biology and Transfusion Medicine SGAIM 2016 – Poster-Sitzungen / SSMIG 2016 – Séances poster 34 P311–P320 Poster SGAIM / Posters SSMIG: Beste 10 Poster / 10 meilleurs posters 38 P321–P328 Poster SGAIM / Posters SSMIG: Postertour 1: Allgemeine Innere Medizin / Médecine interne générale 1 41 P330–P338 Poster SGAIM / Posters SSMIG: Postertour 1: Allgemeine Innere Medizin / Médecine interne générale 2 45 P339–P347 Poster SGAIM / Posters SSMIG: Postertour 1: Allgemeine Innere Medizin / Médecine interne générale 3 47 P348–P356 Poster SGAIM / Posters SSMIG: Postertour 1: Allgemeine Innere Medizin / Médecine interne générale 4 50 P357–P366 Poster SGAIM / Posters SSMIG: Postertour 2: Allgemeine Innere Medizin/Kardiologie/Pneumologie/Gastroenterologie / Médecine générale/Cardiologie/Pneumologie/Gastroentérologie 54 P367–P375 Poster SGAIM / Posters SSMIG: Postertour 2: Kardiologie/Pneumologie/Gastroenterologie Cardiologie/Pneumologie/Gastroentérologie 1 59 P376–P384 Poster SGAIM / Posters SSMIG: Postertour 2: Kardiologie/Pneumologie/Gastroenterologie Cardiologie/Pneumologie/Gastroentérologie 2 PRIMARY AND HOSPITAL CARE – ALLGEMEINE INNERE MEDIZIN 2016;16(SUPPLEMENTUM) INHALT / SOMMAIRE 2 62 P385–P393 Poster SGAIM / Posters SSMIG: Postertour 2: Kardiologie/Pneumologie/Gastroenterologie Cardiologie/Pneumologie/Gastroentérologie 2 Infektiologie/Immunologie/Rheumatologie Infectiologie/Immunologie/Rhumatologie 65 P394–P403 Poster SGAIM / Posters SSMIG: Postertour 2: Infektiologie/Immunologie/Rheumatologie Infectiologie/Immunologie/Rhumatologie 68 P404–P411 Poster SGAIM / Posters SSMIG: Postertour 3: Nephrologie/Arterieller Bluthochdruck Néphrologie/Hypertension artérielle Endokrinologie/Diabetologie Endocrinologie/Diabétologie 70 P412–P419 Poster SGAIM / Posters SSMIG: Postertour 3: Endokrinologie/Diabetologie / Endocrinologie/Diabétologie Onkologie/Notfallmedizin / Oncologie/Urgences 74 P420–P426 Poster SGAIM / Posters SSMIG: Postertour 3: Onkologie/Notfallmedizin Oncologie/Urgences Psychiatrie / Neurologie 76 P427–P435, P329 Poster SGAIM / Posters SSMIG: Postertour 3: Ambulante Allgemeine Innere Medizin/Hausarztmedizin Médecine interne générale ambulatoire/Médecine de famille 1 79 P436–P444 Poster SGAIM / Posters SSMIG: Postertour 3: Ambulante Allgemeine Innere Medizin/Hausarztmedizin Médecine interne générale ambulatoire/Médecine de famille 2 82 P445–P448 Gastgesellschaft SFGG / Société conviée SSPSG: Poster 83 P449–P493 Gastgesellschaft SGH / Société conviée: SSH: Poster 99 P494–P506 Gastgesellschaft SGKPT / Société conviée SSPTC: Poster 103 P507 Gastgesellschaft SGPMR / Société conviée SSMPR: Poster Index of first authors 104 Impressum Primary and Hospital Care Verlag: EMH Schweizerischer Ärzte- ISSN: Printversion: 2297-7155 / Hinweis: Alle in dieser Zeitschrift Offizielles Organ des Berufsverbands verlag AG, Farnsburgerstrasse 8, elektronische Ausgabe: 2297-7163 publizierten Angaben wurden mit der der Haus- und Kinderärzte Schweiz 4132 Muttenz, Tel. +41 (0)61 467 85 55, Erscheinungsweise: 23 Ausgaben grössten Sorgfalt überprüft. Die mit (Hausärzte Schweiz), der Schweizeri- Fax +41 (0)61 467 85 56, www.emh.ch pro Jahr. Verfassernamen gezeichneten Veröf- schen Gesellschaft für Allgemeine fentlichungen geben in erster Linie Innere Medizin SGAIM, der Schweize- Marketing EMH / Inserate: © EMH Schweizerischer Ärzteverlag AG die Auffassung der Autoren und Nicht rischen Gesellschaft für Pädiatrie SGP, Dr. phil. II Karin Würz, Leiterin (EMH), 2016. «Primary and Hospital zwangsläufig die Meinung der Redak- des Kollegiums für Hausarztmedizin Marketing und Kommunikation, Care» ist eine Open- Access-Publika- tion von PrimaryCare wieder. Die an- KHM, der Schweize rischen Akademie Tel. +41 (0)61 467 85 49, Fax +41 (0)61 tion von EMH. Entsprechend gewährt gegebenen Dosierungen, Indikationen für Psychosoma tische und Psycho- 467 85 56, [email protected] EMH allen Nutzern auf der Basis der und Applikationsformen, vor allem voN soziale Medizin SAPPM sowie der Creative-Commons-Lizenz «Namens- Neuzulassungen, sollten in jedem Fall Jungen HausärztiNNen und -ärzte Abonnemente: EMH Schweizerischer neNNung – Nicht kommerziell – Keine mit den Fachinformationen der ver- Schweiz JHaS. Ärzteverlag AG, AboNNemente, Bearbeitungen 4.0 International» das wendeten Medikamente verglicheN Farnsburgerstrasse 8, 4132 Muttenz, zeitlich unbeschränkte Recht, das Werk werden. Redaktion: Dr. Stefan Neuner-Jehle, Tel. +41 (0)61 467 85 75, Fax +41 zu vervielfältigen, zu verbreiten und Dr. Natalie Marty, Dr. Pierre Loeb, (0)61 467 85 76, [email protected] öffentlich zugänglich zu machen unter Herstellung: Schwabe AG, Muttenz, Dr. Edy Riesen, Gabriela Rohner, Abonnementspreise: Für Mitglieder den Bedingungen, dass (1) der Name www.schwabe.ch Dr. Daniel Widmer der Herausgebergesellschaften gelten des Autors genannt wird, (2) das Werk Redaktionsadresse: Ruth Schindler, spezielle Konditionen, die im Detail nicht für kommerzielle Zwecke ver- Redaktionsassistentin, EMH Schweize- unter http://www.primary-care.ch/ wendet wird und (3) das Werk in keiner rischer Ärzteverlag AG, Farnsburger- fuer-leser/aboNNement/ zu finden sind. Weise bearbeitet oder in anderer strasse 8, 4132 Muttenz, Tel. +41 (0)61 Weise verändert wird. Die kommer- 467 85 58, Fax +41 (0)61 467 85 56, AboNNemente für Nichtmitglieder: zielle Nutzung ist Nur mit ausdrück- [email protected], CHF 125.–, Studentenabonnement licher vorgängiger Erlaubnis von EMH Cover photo: www.primary-hospital-care.ch CHF 63.–, jeweils zuzüglich Porto. und auf der Basis einer schriftlichen ©Hai Huy Ton Thot | Dreamstime.com Manuskripteinreichung online: Vereinbarung zulässig. http://www.edmgr.com/primarycare FREIE MITTEILUNGEN SGAIM / COMMUNICATIONS LIBRES SSMIG ALLGEMEINE INNERE MEDIZIN / MÉDECINE INTERNE GÉNÉRALE 1 3 FM230 primary outcome was the recurrence of a first symptomatic, objectively Anti-apolipoprotein A-1 antibodies as a novel confirmed VTE. We examined the association between obesity cardiovascular risk factor in the general population: measures and recurrent VTE using competing risk regression, results from the CoLaus study accounting for non VTE-related death as a competing event. We analyzed BMI and WC both as a categorical and continuous variable. Panagiotis Antiochos1, Pedro Marques-Vidal1, Julien Virzi2, 2 2 1 We adjusted the models for other known risk factors of VTE Sabrina Pagano , Nathalie Satta , François Bastardot , recurrence, including age, gender, unprovoked VTE, active cancer, Oliver Hartley2, Fabrizio Montecucco2, François Mach2, 1 1 2 prior history of VTE, and periods of anticoagulation as a time-varying Gerard Waeber , Peter Vollenweider , Nicolas Vuilleumier covariate. 1Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne; 2 Results: Overall, 122 patients (12.4%) had a first recurrent VTE during Hôpitaux Universitaires de Genève (HUG), Genève, Switzerland a median follow-up period of 30 months. Patients with a BMI <25, 25 Introduction: Preliminary translational and clinical studies have to <30, and ≥30 kg/m2 had a cumulative incidence of recurrent VTE examined the role of autoantibodies against apolipoprotein A-1 of 17. 6%, 11. 5%, and 17. 0% at 36 months, respectively (P = 0.09). (anti-apoA-1 IgG) in atherogenesis and cardiovascular disease (CVD). Patients with a WC <80 cm (W) / <94 cm (M), 80 to <88 cm (W) / 94 We aimed to determine the association between anti-apoA-1 IgG and to <102 (M) cm, and ≥88 cm (W) / ≥102 cm (M) had a cumulative prevalent CVD as well as markers of CV risk
Load more

Recommended publications
  • IQI 17 Acute Stroke Mortality Rate
    AHRQ Quality Indicators™ (AHRQ QI™) ICD-10-CM/PCS Specification v2021 Inpatient Quality Indicator 17 (IQI 17) Acute Stroke Mortality Rate July 2021 Hospital-Level Indicator Type of Score: Rate Prepared by: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services www.qualityindicators.ahrq.gov DESCRIPTION In-hospital deaths per 1,000 hospital discharges with a principal diagnosis of acute stroke for patients ages 18 years and older. Includes metrics for discharges grouped by type of stroke. Excludes transfers to another hospital, cases admitted from a hospice facility, and obstetric discharges. [NOTE: The software provides the rate per hospital discharge. However, common practice reports the measure as per 1,000 discharges. The user must multiply the rate obtained from the software by 1,000 to report in-hospital deaths per 1,000 hospital discharges.] Stratification of Indicator The indicator is stratified into three groups by the type of stroke: Cases are assigned to strata according to a hierarchy based on risk of mortality, with cases being assigned to the stratum with the highest mortality for which the case qualifies. In the case of Stroke Mortality the current hierarchy is as follows: Strata hierarchy (listed from highest mortality to lowest mortality): 1) Intracerebral hemorrhage 2) Subarachnoid hemorrhage 3) Ischemic stroke Strata are mutually exclusive. If a discharge qualifies for more than one stratum, it will be assigned to the stratum with the highest risk of mortality (Intracerebral hemorrhage, Subarachnoid hemorrhage, Ischemic stroke). July 2021 1 of 7 AHRQ QI™ ICD-10-CM/PCS Specification v2021 IQI 17 Acute Stroke Mortality Rate www.qualityindicators.ahrq.gov NUMERATOR Overall Number of deaths (DISP=20) among cases meeting the inclusion and exclusion rules for the denominator.
    [Show full text]
  • 190.23 - Lipids Testing
    Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) 190.23 - Lipids Testing HCPCS Codes (Alphanumeric, CPT AMA) Code Description 80061 Lipid panel 82465 Cholesterol, serum or whole blood, total 83700 Lipoprotein, blood; electrophoretic separation and quantitation 83701 Lipoprotein blood; high resolution fractionation and quantitation of lipoproteins including lipoprotein subclasses when performed (e.g., electrophoresis, ultracentrifugation) 83704 Lipoprotein, blood; quantitation of lipoprotein particle numbers and lipoprotein particle subclasses 83718 Lipoprotein, direct measurement; high density cholesterol (HDL cholesterol) 83721 Lipoprotein, direct measurement, LDL cholesterol 84478 Triglycerides ICD-10-CM Codes Covered by Medicare Program The ICD-10-CM codes in the table below can be viewed on CMS’ website as part of Downloads: Lab Code List, at http://www.cms.gov/Medicare/Coverage/CoverageGenInfo/LabNCDsICD10.html Code Description B25.2 Cytomegaloviral pancreatitis B52.0 Plasmodium malariae malaria with nephropathy E00.0 Congenital iodine-deficiency syndrome, neurological type E00.1 Congenital iodine-deficiency syndrome, myxedematous type E00.2 Congenital iodine-deficiency syndrome, mixed type E00.9 Congenital iodine-deficiency syndrome, unspecified E01.8 Other iodine-deficiency related thyroid disorders and allied conditions E02 Subclinical iodine-deficiency hypothyroidism E03.0 Congenital hypothyroidism with diffuse goiter E03.1 Congenital hypothyroidism without goiter NCD 190.23 January
    [Show full text]
  • Approved Diagnosis Codes for Botox
    MONTANA HEALTHCARE PROGRAMS NOTICE June 12, 2018 Physician, Hospital Inpatient, Hospital Outpatient, Mid-Level Practitioner Effective Immediately REVISED Approved Diagnosis Codes For Botox July 1, 2016, Montana Healthcare Programs removed prior authorization requirement for Botox. These services will be reimbursed only if the claim (UB-04 or CMS-1500) is submitted with an approved diagnosis. Provider claims that are filed on CMS-1500 claim form must use the diagnosis pointer (box 24E) to indicate the specific diagnosis related to the procedure code. Botox is approved for the following diagnosis codes: ICD-10 Diagnosis Code Description G04.1 Tropical spastic paraplegia G11.4 Hereditary spastic paraplegia G24.1 Genetic torsion dystonia G24.2 Idiopathic nonfamilial dystonia G24.3 Spasmodic torticollis G24.4 Idiopathic orofacial dystonia G24.5 Blepharospasm G24.8 Other dystonia G24.9 Dystonia, unspecified G25.3 Myoclonus G25.89 Other specified extrapyramidal and movement disorders G35 Multiple sclerosis G36.1 Acute and subacute hemorrhagic leukoencephalitis [Hurst] G36.8 Other specified acute disseminated demyelination G37.0 Diffuse sclerosis of central nervous system G37.1 Central demyelination of corpus callosum G37.2 Central pontine myelinolysis G37.4 Subacute necrotizing myelitis of central nervous system G37.5 Concentric sclerosis [Balo] of central nervous system G37.8 Other specified demyelinating diseases of central nervous system G37.9 Demyelinating disease of central nervous system, unspecified G43.011 Migraine without aura, intractable,
    [Show full text]
  • Statistical Analysis Plan
    Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This
    [Show full text]
  • TCD CPT and ICD 10 Codes
    TCD CPT Codes /ICD-10 Codes 2021 CPT Codes / ICD-10 Codes CPT codes covered if selection criteria are met: 93886 Transcranial Doppler study of the intracranial arteries; complete study 93888 limited study 93890 vasoreactivity study 93892 emboli detection without intravenous microbubble injection 93893 emboli detection with intravenous microbubble injection Other CPT codes related to the CPB: 61635 Transcatheter placement of intravascular stent(s), intracranial (eg, atherosclerotic stenosis), including balloon angioplasty, if performed REIMBURSEMENT INFORMATION: A complete transcranial Doppler evaluation includes ultrasound examination of the right and left anterior circulation and the posterior circulation, including the vertebral arteries and basilar artery. A limited transcranial Doppler evaluation includes two or less of the below mentioned areas. Excludes hand-held Dopplers that do not provide a hard copy or vascular flow bidirectional analysis. Includes complete transcranial Doppler (TCD) study. Includes patient care required to perform/supervise studies and interpret results. Includes ultrasound evaluation of right/left anterior circulation territories and posterior circulation territory. DWL USA, Inc. 30320 Rancho Viejo Road, Suite 105 San Juan Capistrano, CA 92675 www.dwl.us TCD CPT Codes /ICD-10 Codes 2021 ICD-10 Diagnosis Codes That Support Medical Necessity: D57.00 – D57.02 Hb-SS disease with crisis D57.1 Sickle-cell disease without crisis D57.20 Sickle-cell/Hb-C disease without crisis D57.211 – D57.219 Sickle-cell/Hb-C disease
    [Show full text]
  • Supplementary Data
    Supplementary Data Table S1. ICD-9-CM codes for CAP. ICD-9-CM Code Description 481 Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia] 4821 Pneumonia due to Pseudomonas 4822 Pneumonia due to Haemophilus influenzae 48230 Pneumonia due to Streptococcus, unspecified 48231 Pneumonia due to Streptococcus, group A 48232 Pneumonia due to Streptococcus, group B 48239 Pneumonia due to other Streptococcus 48240 Pneumonia due to Staphylococcus, unspecified 48241 Methicillin susceptible pneumonia due to Staphylococcus aureus 48242 Methicillin resistant pneumonia due to Staphylococcus aureus 48249 Other Staphylococcus pneumonia 48281 Pneumonia due to anaerobes 48282 Pneumonia due to Escherichia coli 48283 Pneumonia due to other gram-negative bacteria 48284 Pneumonia due to Legionnaires' disease 48289 Pneumonia due to other specified bacteria 4829 Bacterial pneumonia, unspecified 4830 Pneumonia due to Mycoplasma pneumoniae 4831 Pneumonia due to Chlamydia 4838 Pneumonia due to other specified organism 4845 Pneumonia in anthrax 485 Bronchopneumonia, organism unspecified 486 Pneumonia, organism unspecified Abbreviation: ICD-9-CM, International Classification of Diseases, 9th revision, Clinical Modification. Table S2. MedAssets PSI score criteria and adaptations. Formula to Calculate Score Corresponding Conditions with PSI Score Criteria (present = 1; absent = 0) Available ICD-9-CM Code Age Age at index in years + Gender Female *(−10) + Nursing home resident Nursing home resident *10 + Excluded from the analysis Neoplastic disease Neoplastic disease
    [Show full text]
  • Incidence, Morbidity and Mortality of Patients with Achalasia in England: Findings from a Nationwide Hospital Database and 4 Million Population Based Data
    Incidence, morbidity and mortality of patients with achalasia in England: findings from a nationwide hospital database and 4 million population based data Appendix A: International Classification of Disease codes for Achalasia (HES) K22 – Achalasia of cardia Appendix B: Read codes (The Health Improvement Network) Appendix B1: Achalasia codes Clinical code Description J100.00 Achalasia of cardia Appendix B2: Clinical codes used to identify Hypertension, Diabetes and lipid lowering drugs Diabetes Clinical code Description C10..00 Diabetes mellitus C100.00 Diabetes mellitus with no mention of complication C100000 Diabetes mellitus, juvenile type, no mention of complication C100011 Insulin dependent diabetes mellitus C100100 Diabetes mellitus, adult onset, no mention of complication C100111 Maturity onset diabetes C100112 Non-insulin dependent diabetes mellitus C100z00 Diabetes mellitus NOS with no mention of complication C101.00 Diabetes mellitus with ketoacidosis C101000 Diabetes mellitus, juvenile type, with ketoacidosis C101100 Diabetes mellitus, adult onset, with ketoacidosis C101y00 Other specified diabetes mellitus with ketoacidosis C101z00 Diabetes mellitus NOS with ketoacidosis C102.00 Diabetes mellitus with hyperosmolar coma C102000 Diabetes mellitus, juvenile type, with hyperosmolar coma C102100 Diabetes mellitus, adult onset, with hyperosmolar coma C102z00 Diabetes mellitus NOS with hyperosmolar coma C103.00 Diabetes mellitus with ketoacidotic coma C103000 Diabetes mellitus, juvenile type, with ketoacidotic coma C103100 Diabetes
    [Show full text]
  • Comprehensive Anatomy and Physiology for ICD-10-CM and ICD-10-PCS Coding Contents
    2016 Optum Learning: Comprehensive Anatomy and Physiology for ICD-10-CM and ICD-10-PCS Coding Contents Introduction ................................................................................................................1 Welcome to Comprehensive Anatomy and Physiology for ICD-10-CM and ICD-10-PCS Coding .....................................................................1 Summary ....................................................................................................11 Chapter 1. Introduction to the Human Body ........................................................13 Anatomy Overview .....................................................................................13 Figure 1.1: Tissue ...................................................................................14 Figure 1.2: Anatomical Position .............................................................17 Figure 1.3: Body Planes ..........................................................................19 Figure 1.4: Motion .................................................................................20 Summary ....................................................................................................21 Knowledge Assessment Questions ..............................................................22 Chapter 2. ICD-10-CM: Integumentary System ....................................................25 Anatomic Overview ....................................................................................25 Figure 2.1: Skin .....................................................................................25
    [Show full text]
  • 336 Naegeli's
    336 INDEX N Naegeli's Narrowing - continued - disease 287.1 - artery NEC - continued - leukemia, monocytic (M9863/3) 205.1 -- cerebellar 433.8 Naffziger's syndrome 353.0 -- choroidal 433.8 Naga sore (see also Ulcer, skin) 707.9 -- communicative posterior 433.8 Nagele's pelvis 738.6 -- coronary 414.0 - with disproportion 653.0 --- congenital 090.5 -- causing obstructed labor 660.1 --- due to syphilis 093.8 -- fetus or newborn 763.1 -- hypophyseal 433.8 Nail - see also condition -- pontine 433.8 - biting 307.9 -- precerebral NEC 433.9 - patella syndrome 756.8 --- multiple or bilateral 433.3 Nanism, nanosomia (see also Dwarfism) -- vertebral 433.2 259.4 --- with other precerebral artery 433.3 - pituitary 253.3 --- bilateral 433.3 - renis, renalis 588.0 auditory canal (external) 380.5 Nanukayami 100.8 cerebral arteries 437.0 Napkin rash 691.0 cicatricial - see Cicatrix Narcissism 302.8 eustachian tube 381.6 Narcolepsy 347 eyelid 374.4 Narcosis - intervertebral disc or space NEC - see - carbon dioxide (respiratory) 786.0 Degeneration, intervertebral disc - due to drug - joint space, hip 719.8 -- correct substance properly - larynx 478.7 administered 780.0 mesenteric artery (with gangrene) 557.0 -- overdose or wrong substance given or - palate 524.8 taken 977.9 - palpebral fissure 374.4 --- specified drug - see Table of drugs - retinal artery 362.1 and chemicals - ureter 593.3 Narcotism (chronic) (see also Dependence) - urethra (see also Stricture, urethra) 598.9 304.9 Narrowness, abnormal. eyelid 743.6 - acute NEC Nasal- see condition correct
    [Show full text]
  • The 2012 Coding Manual Collection
    The 2012 Coding Manual Collection SaMple pageS ICD-9-CM Manual, Volumes 1, 2 & 3 (Hospital Edition) ICD-9-CM Manual, Volume 1 & 2 (Professional Edition) HCPCS Level II Manual The following 10 sample pages are from HCpro’s 2011 ICD-9-CM Coding Manual, Volumes 1, 2 & 3 SaMple pageS ICD-9-CM Manual, Volumes 1, 2 & 3 (Hospital Edition) 2011 ICD-9-CM Conventions HCPro’s ICD-9-CM manuals include all the symbols and conventions Please note: Certain categories of codes only consider a particular set of found in the government’s official version (see Preface and ICD-9-CM fifth digits to be a CC condition. Official Guidelines for Coding and Reporting). In addition, HCPro’s ICD- • For example: 9-CM manuals include the following icons and color-coded conventions: Category 403.9x. CC 1 ✓4 TH Fourth digit required. In order to accurately assign a diagnosis This means that ICD-9 code 403.90 is not considered a CC condition, but from this category, it requires the assignment of a fourth digit. 403.91 is designated as a CC condition. • For example: Category 465.x requires a fourth digit of a 0, 8, or 9 to be assigned an accurate code. MCC Major Complication and Comorbidity. This diagnosis is considered a major complication and/comorbidity. Assignment of these ✓5 TH Fifth digit required. In order to accurately assign a diagnosis from diagnoses as an additional code may impact DRG assignment. this category, it requires the assignment of a fifth digit. • For example: 585.6 (End stage renal disease) is • For example: Category 642.0x requires a fifth digit of a 0, 1, 2, 3, or designated as an MCC.
    [Show full text]
  • Partial Thromboplastin Time (PTT)
    2020 MEDICARE NATIONAL COVERAGE DETERMINATION (NCD) - 190.16 PROCEDURE CODE: 85730 Partial Thromboplastin Time (PTT) DLS TEST CODES AND NAMES 516 PART. THROM. TIME (PTT) ICD-10 CODE DESCRIPTION A01.00 Typhoid fever, unspecified A01.01 Typhoid meningitis A01.02 Typhoid fever with heart involvement A01.03 Typhoid pneumonia A01.04 Typhoid arthritis A01.05 Typhoid osteomyelitis A01.09 Typhoid fever with other complications A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02.0 Salmonella enteritis A02.1 Salmonella sepsis A02.20 Localized salmonella infection, unspecified A02.21 Salmonella meningitis A02.22 Salmonella pneumonia A02.23 Salmonella arthritis A02.24 Salmonella osteomyelitis A02.25 Salmonella pyelonephritis A02.29 Salmonella with other localized infection A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A41.9 Sepsis, unspecified organism A91 Dengue hemorrhagic fever A92.0 Chikungunya virus disease A95.0 Sylvatic yellow fever A95.1 Urban yellow fever A95.9 Yellow fever, unspecified A96.0 Junin hemorrhagic fever A96.1 Machupo hemorrhagic fever A96.8 Other arenaviral hemorrhagic fevers A96.9 Arenaviral hemorrhagic fever, unspecified A98.0 Crimean-Congo hemorrhagic fever A98.1 Omsk hemorrhagic fever A98.2 Kyasanur Forest disease Source: www.cms.hhs.gov/mcd Prothombin Time Effective date: 10-1-2016, last updated 1-22-2020 Page 1 of 46 2020 MEDICARE NATIONAL COVERAGE DETERMINATION (NCD) - 190.16 PROCEDURE CODE: 85730 Partial Thromboplastin
    [Show full text]
  • 190.17 - Prothrombin Time (PT)
    Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) 190.17 - Prothrombin Time (PT) HCPCS Codes (Alphanumeric, CPT AMA) Code Description 85610 Prothrombin Time ICD-10-CM Codes Covered by Medicare Program The ICD-10-CM codes in the table below can be viewed on CMS’ website as part of Downloads: Lab Code List, at http://www.cms.gov/Medicare/Coverage/CoverageGenInfo/LabNCDsICD10.html Code Description A01.00 Typhoid fever, unspecified A01.01 Typhoid meningitis A01.02 Typhoid fever with heart involvement A01.03 Typhoid pneumonia A01.04 Typhoid arthritis A01.05 Typhoid osteomyelitis A01.09 Typhoid fever with other complications A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02.0 Salmonella enteritis A02.1 Salmonella sepsis A02.20 Localized salmonella infection, unspecified A02.21 Salmonella meningitis A02.22 Salmonella pneumonia A02.23 Salmonella arthritis A02.24 Salmonella osteomyelitis NCD 190.17 January 2021 Changes ICD-10-CM Version – Red Fu Associates, Ltd. January 2021 1 Medicare National Coverage Determinations (NCD) Coding Policy Manual and Change Report (ICD-10-CM) Code Description A02.25 Salmonella pyelonephritis A02.29 Salmonella with other localized infection A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A18.84 Tuberculosis of heart A41.9 Sepsis, unspecified organism A91 Dengue hemorrhagic fever A92.0 Chikungunya virus disease A95.0 Sylvatic yellow fever A95.1 Urban yellow fever
    [Show full text]